Because
of their self-recovery ability and fatigue resistance,
double-network (DN) hydrogels with hybrid ionical–covalent
cross-linking have received wide attention. In this work, by a simple
“one-pot” method, a novel kind of hybrid ionic–covalent
chitosan/poly(sulfobetaine methacrylate) (CS/PSBMA) DN hydrogels was prepared. The
hydrogels showed high tensile strength (2.0 MPa), strong elastic modulus
(0.5 MPa), fast self-recovery ability as well as excellent fatigue
resistance, high mechanical strength, and toughness retention rate
after soaking in water for 24 h. Additionally, the mechanical properties
of the DN gels were enhanced after stretch and relaxation because
of the rearrangement of the CS network. More excitingly, because of
the antifouling feature of PSBMA and the inherent antibacterial property
of CS, the hybrid DN hydrogels demonstrated a “repel and kill”
effect on microorganisms. The CS/PSBMA DN hydrogels may find potential
applications in biomedical fields, such as artificial connective tissues,
implantable devices, and wound dressing.
A dual-sensitive drug delivery system (DDS) based on graphene oxide (GO) which is simultaneously loaded with proapoptotic peptides and anticancer drugs was rationally designed and fabricated for cancer synergetic therapy. Specifically, a kind of cell apoptosis peptide (KLAKLAK) 2 (KLA) was anchored on the surface of GO via a disulfide bond to obtain GO-SS-KLA. Then, the aromatic anticancer drug doxorubicin (DOX) was loaded on GO through π−π conjugation and hydrogen bonding interactions. Finally, bovine serum albumin (BSA) was used to coat the GO carrier to obtain a biological medium-stable GO-based DDS
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.